Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Considers Increasing Production Of Avian Flu Vaccine

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare is considering increasing production of avian flu vaccine, adding to the current stockpile of 10 million doses. In preparing for the possibility of an avian flu epidemic, with vaccine production taking six months, the government plans to produce the pandemic vaccine based on the highly mutable H5N1 type virus, to be used by medical workers immediately following an epidemic outbreak. A more effective vaccine can be produced later on for the general population. (Click here for more-Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel